Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Juni 2020

Biotek-snakken — Juni 2020

Planlagt Fastgjort Låst Flyttet Biotek-snakken
265 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #23

    Har en lille post fra 35,5 pga din hype 😉 Meget fin stigning den seneste tid.

    1 Reply Last reply
    0
    • J Offline
      J Offline
      Jazzz
      wrote on sidst redigeret af
      #24

      ????????

      1 Reply Last reply
      0
      • J Offline
        J Offline
        Jazzz
        wrote on sidst redigeret af
        #25

        Super!

        1 Reply Last reply
        0
        • J Offline
          J Offline
          Jazzz
          wrote on sidst redigeret af
          #26

          Saniona (som jeg har “hypet” før) https://s3-eu-west-1.amazonaws.com/rdey-cms-prod/app/uploads/2020/05/saniona-6.pdf

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Sukkeralf
            wrote on sidst redigeret af
            #27

            Mens Enhertu´s brede udviklingsprogram skrider sikkert frem og Zymeworks ZW49 ikke lader til at have travlt, så må man prøve at finde lyspunkterne:

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #28

              Although Enhertu was shown to reduce the risk of death by 41% in third-line HER2 positive gastric cancer patients, one potential wrinkle that emerged at ASCO was a lack of sufficient activity in HER2 'low' gastric cancer patients. AstraZeneca has touted the potential opportunity of using Enhertu to treat breast cancer patients who express low levels of HER2 who are not served by the targeted agents Herceptin and Perjeta (both of which are marketed by Roche).

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #29

                During an investor call earlier this week, Baselga played down concerns there could be read across here from gastric to breast cancer and said his views on potentially establishing Enhertu in a broader cohort of breast cancer patients are unchanged, largely on the strength of extensive data AstraZeneca has seen in this setting.

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #30

                  Just a moment...

                  favicon

                  (www.firstwordpharma.com)

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #31

                    Når ZW49 mulighed for at ramme markedet er betydeligt senere end Enhertu, så kan man håbe på en bedre bivirkningsprofil og nogenlunde samme effekt, men bedst af alt ville være, hvis ZW49 kunne vise effekt i Her2 low !!

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #32

                      Lets go - Her2 low.............bliver ZW49´s motto !

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #33

                        Lidt til den negative side pt.

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #34

                          Ligesom kursen har været lidt til den negative side. Men man kan komme langt med et godt Motto 🙂

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            BioShare
                            wrote on sidst redigeret af
                            #35

                            Fate i emi - var det ikke Solsen, som nappede en bid? Fate expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. https://finance.yahoo.com/news/fate-therapeutics-announces-proposed-public-200110051.html

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              BioShare
                              wrote on sidst redigeret af
                              #36

                              Tror godt den kan sætte sig lidt oven på den melding....og indtil det er endeligt på plads. Muligt man kan få en lille ekstra rabat på et frimærke...vi får se.

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                Jazzz
                                wrote on sidst redigeret af
                                #37

                                Saniona; https://ml-eu.globenewswire.com/Resource/Download/87e471ad-e210-4794-bf65-60172644f0eb

                                1 Reply Last reply
                                0
                                • L Offline
                                  L Offline
                                  lahn1
                                  wrote on sidst redigeret af
                                  #38

                                  Så køre toget 😉 SUTRO med nye data på STRO-002 den 22. juni.https://www.sutrobio.com/sutro-biopharma-to-present-new-preclinical-data-on-its-stro-002-antibody-drug-conjugate-at-the-upcoming-aacr-2020-virtual-meeting-on-june-22-2020/

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    Bjæssing09
                                    wrote on sidst redigeret af
                                    #39

                                    Forstår ikke hvorfor Saniona stadig roder rundt i niveauet 26-27 SEK, men det bliver der nok lavet om på, når Tesofensine bliver godkendt i Mexico indenfor 1-2 mdr og Tesomet rykker over i fase III i løbet af efteråret.......så taler vi kurs 50-60 SEK som minimum.

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      Mcjean
                                      wrote on sidst redigeret af
                                      #40

                                      Måske man skulle supplere lidt i SUTRO

                                      1 Reply Last reply
                                      0
                                      • M Offline
                                        M Offline
                                        Mcjean
                                        wrote on sidst redigeret af
                                        #41

                                        Den har ligget helt underdrejet siden emi.

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          BioShare
                                          wrote on sidst redigeret af
                                          #42

                                          ...haha FATE stiger +20% på emi - det er vist ikke ret tit jeg har set det ske på biotek
                                          🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper